Juan Osorio: Presenting on Fc-optimized CD40 antibody and systemic antitumor immunity at NCI Rising Scholars
Juan Osorio, Assistant Attending at Memorial Sloan Kettering Cancer Center and Director of Clinical Operations and Translational Immunology at The Rockefeller University, shared a post on X:
“Interested in myeloid cell anti-tumor immunity? I’ll be presenting at NCI Rising Scholars Seminar Series on 17 Apr our work on Fc-optimized CD40 Agonistic Antibody and TLS formation and induction of Systemic Antitumor Immunity.”
Christine Lovly, Associate Professor of Medicine with Tenure at the Vanderbilt University Medical Center and Vanderbilt Ingram Cancer Center, shared this post, adding:
“Check out this NCI Seminar from Juan Osorio on Fc-optimizer CD40 agnostic antibody and TLS formation.
Juan Osorio is a brilliant junior investigator, rising star, and really nice person! Please support him and his work! You will be wowed!”
More posts featuring Christine Lovly.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023